ORGANOGENESIS HOLDINGS INC. Income Taxes Paid
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Income Taxes Paid of $5.35 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2026-02-26
- ORGANOGENESIS HOLDINGS INC. income taxes paid for the quarter ending 2025-12-31 was $1.26M, a 14.40% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. income taxes paid for the quarter ending 2025-09-30 was $295.00K, a 57.68% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. income taxes paid for the quarter ending 2025-06-30 was $3.64M, a 23.52% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. income taxes paid for the quarter ending 2025-03-31 was $150.00K, a 328.57% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. income taxes paid for fiscal 2025 was $5.35M, a 23.24% decline from fiscal 2024.
- ORGANOGENESIS HOLDINGS INC. income taxes paid for fiscal 2024 was $6.96M, a 128.21% increase from fiscal 2023.
- ORGANOGENESIS HOLDINGS INC. income taxes paid for fiscal 2023 was $3.05M, a 154.12% increase from fiscal 2022.
- ORGANOGENESIS HOLDINGS INC. income taxes paid for fiscal 2022 was $1.20M, a 97.86% increase from fiscal 2021.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month |
|---|---|---|---|---|
| 2025-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.55M derived: sum of 2 quarters · filed 2026-02-26 | $5.20M derived: sum of 3 quarters · filed 2026-02-26 | $5.35M 10-K · filed 2026-02-26 |
| 2025-09-30 | $295.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $3.94M derived: sum of 2 quarters · filed 2025-11-06 | $4.09M 10-Q · filed 2025-11-06 | $5.56M derived: sum of 4 quarters · filed 2026-02-26 |
| 2025-06-30 | $3.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $3.79M 10-Q · filed 2025-08-07 | $5.26M derived: sum of 3 quarters · filed 2026-02-26 | $5.96M derived: sum of 4 quarters · filed 2026-02-26 |
| 2025-03-31 | $150.00K 10-Q · filed 2025-05-08 | $1.62M derived: sum of 2 quarters · filed 2026-02-26 | $2.32M derived: sum of 3 quarters · filed 2026-02-26 | $7.08M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.17M derived: sum of 2 quarters · filed 2026-02-26 | $6.93M derived: sum of 3 quarters · filed 2026-02-26 | $6.96M 10-K · filed 2026-02-26 |
| 2024-09-30 | $697.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $5.46M derived: sum of 2 quarters · filed 2025-11-06 | $5.49M 10-Q · filed 2025-11-06 | $5.52M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $4.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $4.80M 10-Q · filed 2025-08-07 | $4.83M derived: sum of 3 quarters · filed 2026-02-26 | $4.83M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $35.00K 10-Q · filed 2025-05-08 | $66.00K derived: sum of 2 quarters · filed 2026-02-26 | $65.00K derived: sum of 3 quarters · filed 2026-02-26 | $2.96M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $30.00K derived: sum of 2 quarters · filed 2026-02-26 | $2.92M derived: sum of 3 quarters · filed 2026-02-26 | $3.05M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $2.89M derived: sum of 2 quarters · filed 2024-11-12 | $3.02M 10-Q · filed 2024-11-12 | $3.25M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $2.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $3.02M 10-Q · filed 2024-08-08 | $3.25M derived: sum of 3 quarters · filed 2025-02-27 | $3.25M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $128.00K 10-Q · filed 2024-05-09 | $355.00K derived: sum of 2 quarters · filed 2025-02-27 | $355.00K derived: sum of 3 quarters · filed 2025-02-27 | $1.32M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $227.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $227.00K derived: sum of 2 quarters · filed 2025-02-27 | $1.20M derived: sum of 3 quarters · filed 2025-02-27 | $1.20M 10-K · filed 2025-02-27 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $970.00K derived: sum of 2 quarters · filed 2023-11-09 | $974.00K 10-Q · filed 2023-11-09 | $999.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $970.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $974.00K 10-Q · filed 2023-08-09 | $999.00K derived: sum of 3 quarters · filed 2024-02-29 | $999.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $4.00K 10-Q · filed 2023-05-10 | $29.00K derived: sum of 2 quarters · filed 2024-02-29 | $29.00K derived: sum of 3 quarters · filed 2024-02-29 | $611.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $25.00K derived: sum of 2 quarters · filed 2024-02-29 | $607.00K derived: sum of 3 quarters · filed 2024-02-29 | $607.00K 10-K · filed 2024-02-29 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $582.00K derived: sum of 2 quarters · filed 2022-11-09 | $582.00K 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $582.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $582.00K 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $61.00K 10-K · filed 2023-03-01 | |||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-11 | -$61.00K derived: sum of 2 quarters · filed 2022-03-01 | -$18.00K derived: sum of 3 quarters · filed 2022-03-01 | -$9.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$18.00K derived: sum of 2 quarters · filed 2022-03-01 | -$9.00K derived: sum of 3 quarters · filed 2022-03-01 | $49.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | $43.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $52.00K derived: sum of 2 quarters · filed 2020-11-09 | $110.00K 10-Q · filed 2020-11-09 | $56.00K derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $67.00K 10-Q · filed 2020-08-10 | $13.00K derived: sum of 3 quarters · filed 2021-03-16 | $13.00K derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-03-31 | $58.00K 10-Q · filed 2020-05-11 | $4.00K derived: sum of 2 quarters · filed 2021-03-16 | $4.00K derived: sum of 3 quarters · filed 2021-03-16 | $65.00K derived: sum of 4 quarters · filed 2021-03-16 |
| 2018-12-31 | -$54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | -$54.00K derived: sum of 2 quarters · filed 2021-03-16 | $7.00K derived: sum of 3 quarters · filed 2021-03-16 | $8.00K 10-K · filed 2021-03-16 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $61.00K derived: sum of 2 quarters · filed 2019-11-12 | $62.00K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $61.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $62.00K 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | $1.00K 10-Q · filed 2019-05-10 | |||
| 2017-12-31 | $96.00K 10-K · filed 2020-03-09 | |||
| 2016-12-31 | $29.00K 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |